Short Term Status of Free Dermal Fat Autografts for Complex Craniofacial Wounds
Launched by DUFRESNE, CRAIG, MD, PC · Mar 12, 2019
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking into a treatment called free dermal fat autografting for patients with complex wounds on the head and face. These are wounds that have not healed properly despite standard treatments. The researchers want to see how well this type of graft, which involves taking fat from the patient’s own body and using it to help heal the wound, works over time. To participate, patients need to have a severe wound that has not responded to previous treatments, and they must have had at least two failed attempts to fix the wound or treat any infections.
If someone qualifies for this study, they will have had the grafting procedure done within the last week. During the trial, their healing progress will be monitored for up to two years, which will involve taking photographs and small samples of the grafted area. This trial is important because it aims to find better ways to help patients with challenging wounds heal effectively. Participants will need to be able to understand and consent to the study, and they must speak English.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Presence of a complex craniofacial wound, defined by failure of initial reconstructive and antibiotic treatment and the presence of chronic infection, exposed hardware, irradiated local tissue, or soft tissue volume loss
- • Presence of wound contracture, breakdown of overlying tissue, or challenging anatomical deformities
- • Patient has had two or more failed reconstructive attempts or has failed two or more attempts to treat local infection
- • Speak, read, and understand English
- • Willing to freely give consent
- • Is able or has a legal representative to give consent
- Exclusion Criteria:
- • Absence of a complex craniofacial wound, defined by failure of initial reconstructive and antibiotic treatment and the presence of chronic infection, exposed hardware, irradiated local tissue, or soft tissue volume loss
- • Absence of wound contracture, breakdown of overlying tissue, or challenging aesthetic deformities
- • Patient has not had two or more failed reconstructive attempts or has not failed two or more attempts to treat local infection
- • Does not speak, read, or understand English
- • Unwilling to freely give consent
- • Is unable or does not have a legal representative to give consent
About Dufresne, Craig, Md, Pc
Dufresne, Craig, MD, PC is a clinical trial sponsor dedicated to advancing medical research and improving patient outcomes through innovative studies. Led by Dr. Craig Dufresne, a seasoned physician with extensive expertise in clinical practice and research, the organization focuses on a range of therapeutic areas, ensuring rigorous adherence to ethical standards and regulatory compliance. Committed to fostering collaboration with healthcare professionals and research institutions, Dufresne, Craig, MD, PC aims to contribute valuable insights to the medical community while prioritizing patient safety and well-being in all trial endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Fairfax, Virginia, United States
Patients applied
Trial Officials
Craig R Dufresne, MD
Principal Investigator
Dr Craig R Dufresne, MD, PC
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials